Illum LRH, Bak ST, Lund S et al (2018) DNA methylation in epigenetic inheritance of metabolic diseases through the male germ line. J Mol Endocrinol 60:R39–R56. https://doi.org/10.1530/JME-17-0189

Article  CAS  PubMed  Google Scholar 

Cho YH, McCullough LE, Gammon MD et al (2015) Promoter hypermethylation in white blood cell DNA and breast cancer risk. J Cancer 6:819–824. https://doi.org/10.7150/jca.12174

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lønning PE, Berge EO, Bjørnslett M et al (2018) Blood cell BRCA1 promoter methylation status and ovarian cancer risk. Ann Intern Med 168:326–334. https://doi.org/10.7326/M17-0101

Article  PubMed  Google Scholar 

Ruscito I, Gasparri ML, De Marco MP et al (2021) The clinical and pathological profile of BRCA1 gene methylated breast cancer women: a meta-analysis. Cancers (Basel) 13:1391. https://doi.org/10.3390/cancers13061391

Article  CAS  Google Scholar 

Stefansson OA, Villanueva A, Vidal A et al (2012) BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer. Epigenetics 7:1225–1229. https://doi.org/10.4161/epi.22561

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giri AK, Aittokallio T (2019) DNMT inhibitors increase methylation in the cancer genome. Front Pharmacol 10:385. https://doi.org/10.3389/fphar.2019.00385

Article  CAS  PubMed  PubMed Central  Google Scholar 

McMahon KW, Karunasena E, Ahuja N (2017) The roles of DNA methylation in the stages of cancer. Cancer J 23:257–261. https://doi.org/10.1097/PPO.0000000000000279

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aref-Eshghi MJD, Pedro VP et al (2020) Genetic and epigenetic profiling of BRCA1/2 in ovarian tumors reveals additive diagnostic yield and evidence of a genomic BRCA1/2 DNA methylation signature. J Hum Genet 65:865–873. https://doi.org/10.1038/s10038-020-0780-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vos S, van Diest PJ, Moelans CB (2018) A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not? Crit Rev Oncol Hematol 127:29–41. https://doi.org/10.1016/j.critrevonc.2018.05.008

Article  PubMed  Google Scholar 

Nguyen-Dumont T, Karpinski P, Sasiadek MM et al (2020) Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer? Genet Res (Camb) 102:e6. https://doi.org/10.1017/S0016672320000075

Article  CAS  Google Scholar 

Kitsera N, Shparyk YA, Helner N et al (2016) Detection of gene mutation in the 185del AG BRCA1 in families with hereditary breast cancer. Hereditary Genetics 5:1–4. https://doi.org/10.4172/2161-1041.1000171

Article  Google Scholar 

Gorodetska I, Serga S, Levkovich N et al (2015) The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine. Hered Cancer Clin Pract 13:19. https://doi.org/10.1186/s13053-015-0040-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kitsera N, Ya S, Bilynsky B et al (2014) BRCA1 4153delA mutation (”Baltic/Black Sea”) in breast cancer patients in Ukraine. J Nowotwory 64:246–250. https://doi.org/10.5603/NJO.2014.0039

Article  Google Scholar 

Zakhartseva LM, Gorovenko NG, Podolskaya SV et al (2009) Breast cancer immunohistochemical features in young women with BRCA1/2 mutations. Exp Oncol 31:174–178

CAS  PubMed  Google Scholar 

Lobanova OE, Rossokha ZI, Medvedieva NL et al (2021) Prevalence of BRCA1 and BRCA2 genes promoter hypermethylation in breast cancer tissue. Exp Oncol 43:56–60. https://doi.org/10.32471/exp-oncology.2312-8852.43(1):15703

Article  CAS  PubMed  Google Scholar 

Paliychuk O, Polishchuk L, Rossokha Z et al (2018) Molecular-genetic models for prognosis of development of tumors of reproductive system in women with family history of cancer. Exp Oncol 40:59–67. https://doi.org/10.31768/2312-8852.2018.40(1):59-67

Article  CAS  PubMed  Google Scholar 

Gorodetska I, Serga S, Lahuta T et al (2017) Prevalence of two BRCA1 mutations, 5382insC and 300T > G, in ovarian cancer patients from Ukraine. Fam Cancer 16:471–476. https://doi.org/10.1007/s10689-017-9978-9

Article  CAS  PubMed  Google Scholar 

Saif I, Bouziyane A, Benhessou M et al (2021) Detection of hypermethylation BRCA1/2 gene promoter in breast tumours among Moroccan women. Mol Biol Rep 48:7147–7152. https://doi.org/10.1007/s11033-021-06705-2

Article  CAS  PubMed  Google Scholar 

Morizono A, Tanabe M, Ikemura M, Sasaki T, Ushiku T, Seto Y (2021) Loss of BRCA1 expression and morphological features associated with BRCA1 promoter methylation status in triple-negative breast cancer. J Hum Genet 66:785–793. https://doi.org/10.1038/s10038-021-00911-3

Article  CAS  PubMed  Google Scholar 

Glodzik D, Bosch A, Hartman J et al (2020) Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers. Nat Commun 11:3747. https://doi.org/10.1038/s41467-020-17537-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prajzendanc K, Domagała P, Hybiak J et al (2019) BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer. Int J Cancer 146:1293–1298. https://doi.org/10.1002/ijc.32655

Article  CAS  PubMed  Google Scholar 

Staaf J, Glodzik D, Bosch A et al (2019) Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study. Nat Med 25:1526–1533. https://doi.org/10.1038/s41591-019-0582-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stefansson OA, Hilmarsdottir H, Olafsdottir K et al (2019) BRCA1 promoter methylation status in 1031 primary breast cancers predicts favorable outcomes following chemotherapy. JNCI Cancer Spectr 4:pkz100. https://doi.org/10.1093/jncics/pkz100

Article  PubMed  PubMed Central  Google Scholar 

Paydar P, Asadikaram G, Nejad HZ et al (2019) Epigenetic modulation of BRCA-1 and MGMT genes, and histones H4 and H3 are associated with breast tumors. J Cell Biochem 120:13726–13736. https://doi.org/10.1002/jcb.28645

Article  CAS  PubMed  Google Scholar 

Vu TL, Nguyen TT, Doan VTH et al (2018) Methylation profiles of BRCA1, RASSF1A and GSTP1 in Vietnamese women with breast cancer. Asian Pac J Cancer Prev 19:1887–1893. https://doi.org/10.22034/APJCP.2018.19.7.1887

Article  CAS  PubMed  PubMed Central  Google Scholar 

Evans DGR, van Veen EM, Byers HJ et al (2018) A Dominantly inherited 5’ UTR variant causing methylation-associated silencing of BRCA1 as a Cause of breast and ovarian cancer. Am J Hum Genet 103:213–220. https://doi.org/10.1016/j.ajhg.2018.07.002

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harahap WA, Sudji IR, Nindrea RD (2018) BRCA1 promoter methylation and clinicopathological characteristics in sporadic breast cancer patients in Indonesia. Asian Pac J Cancer Prev 19:2643–2649. https://doi.org/10.22034/APJCP.2018.19.9.2643

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vos S, Moelans CB, van Diest PJ (2017) BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers. Breast Cancer Res 19:64. https://doi.org/10.1186/s13058-017-0856-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Felicio PS, Melendez ME, Arantes LM et al (2017) Genetic and epigenetic characterization of the BRCA1 gene in Brazilian women at-risk for hereditary breast cancer. Oncotarget 8:2850–2862. https://doi.org/10.18632/oncotarget.13750

Article  PubMed  Google Scholar 

Kumar M, Sahu RK, Goyal A et al (2017) BRCA1 Promoter methylation and expression - associations with ER+, PR+ and HER2+ subtypes of breast carcinoma. Asian Pac J Cancer Prev 18:3293–3299. https://doi.org/10.22034/APJCP.2017.18.12.3293

Article  PubMed  PubMed Central  Google Scholar 

Hosny MM, Sabek NA, El-Abaseri TB et al (2016) Promoter methylation status of breast cancer susceptibility gene 1 and 17 beta hydroxysteroid dehydrogenase type 1 gene in sporadic breast cancer patients. Int J Breast Cancer 2016:9545241. https://doi.org/10.1155/2016/9545241

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shakeri H, Fakhrjou A, Nikanfar A et al (2016) Methylation analysis of BRCA1 and APC in breast cancer and it’s relationship to clinicopathological features. Clin Lab 62:2333–2337. https://doi.org/10.7754/Clin.Lab.2016.160418

Article  CAS  PubMed  Google Scholar 

Guo Yu, Li J, Zhang W (2016) [Analysis the methylation and clinic significant of BRCA1 gene in Uyghur and Han nationality patients with sporadic breast cancer in Xinjiang]. J Xinjiang Med Univ 39:155–159. https://xjyy.cbpt.cnki.net/WKD2/WebPublication/paperDigest.aspx?paperID=31923de4-0b73-4210-8dd6-cd39f27ab680#. Accessed 20 Jan 2022.

Wu L, Wang J (2016) Study on the correlation between abnormal DNA methylation and clinical features of breast cancer. J Med 11:82–86. https://doi.org/10.11969/j.issn.1673-548X.2016.11.021

Article  Google Scholar 

Liu L, Sun L, Li C et al (2015) Quantitative detection of methylation of FHIT and BRCA1 promoters in the serum of ductal breast cancer patients. Biomed Mater Eng 26:S2217–S2222. https://doi.org/10.3233/BME-151527

Article  CAS  PubMed  Google Scholar